Patient characteristics at baseline
Adherence rate (%) | |||
Patients (n) | Median | IQR | |
Overall | 6424 | 50.0 | 25.0–71.4 |
Age | |||
18–44 | 213 | 33.3 | 0.0–60.0 |
45–54 | 690 | 40.0 | 20.0–63.4 |
55–64 | 1642 | 50.0 | 25.0–69.2 |
65+ | 3879 | 50.0 | 25.0–75.0 |
Gender | |||
Female | 3014 | 50.0 | 25.0–71.4 |
Male | 3410 | 50.0 | 25.0–71.4 |
Socioeconomic status | |||
1 (most disadvantaged) | 904 | 50.0 | 25.0–70.0 |
2 | 670 | 42.9 | 20.0–66.7 |
3 | 1438 | 50.0 | 25.0–75.0 |
4 | 1256 | 50.0 | 25.0–71.4 |
5 (most advantaged) | 2156 | 50.0 | 25.0–71.4 |
Remoteness | |||
Major cities | 5143 | 50.0 | 25.0–71.4 |
Regional/remote | 1281 | 53.8 | 28.6–75.0 |
Medication | |||
Insulin | 890 | 50.0 | 28.6–72.0 |
Oral agents only | 3734 | 50.0 | 25.0–71.4 |
No medication | 1800 | 50.0 | 20.0–70.0 |